Togitani Kazuto, Yamamoto Moe, Tanaka Soichiro, Aono Rei, Uemura Yoshiki
Department of Hematology, Chikamori Hospital, Kochi, Japan.
Department of Gastroenterology, Chikamori Hospital, Kochi, Japan.
Case Rep Hematol. 2025 Jul 8;2025:1402790. doi: 10.1155/crh/1402790. eCollection 2025.
Acquired factor V deficiency (AFVD) is a rare coagulation abnormality associated with infectious diseases, antibiotics, surgery, autoimmune diseases, and malignancy, which causality is difficult to prove. Here, we report a case of a 90-year-old woman who developed melena following antibiotic treatment for pneumonia. She had been on cefepime for bacterial pneumonia for 2 months to 2 weeks prior to her arrival in the emergency room. Upon presentation, she had severe anemia (Hb: 6.7 g/dL) and prolonged PT (74.3 s) and activated partial thromboplastin time (APTT) (161.9 s). Coagulation studies revealed incomplete correction of the APTT in a 1:1 mixing study with normal pooled plasma, factor V activity of 0%, and a factor V inhibitor titer of 13 Bethesda units, confirming the diagnosis of AFVD. Since the antibiotics were not recognized as the cause, the coagulation abnormality worsened after their readministration. The melena subsequently improved with platelet transfusion and administration of tranexamic acid, while prednisolone-resistant coagulation abnormalities improved with cyclosporine A (CsA) treatment. This case shows the importance of avoiding suspected drugs and the effectiveness of CsA as a second-line treatment of AFVD.
获得性因子V缺乏症(AFVD)是一种罕见的凝血异常,与传染病、抗生素、手术、自身免疫性疾病和恶性肿瘤有关,其因果关系难以证实。在此,我们报告一例90岁女性患者,她在接受抗生素治疗肺炎后出现黑便。在她抵达急诊室前2个月至2周,她一直在使用头孢吡肟治疗细菌性肺炎。就诊时,她有严重贫血(血红蛋白:6.7g/dL),凝血酶原时间延长(74.3秒)和活化部分凝血活酶时间(APTT)延长(161.9秒)。凝血研究显示,在与正常混合血浆进行的1:1混合试验中,APTT未完全纠正,因子V活性为0%,因子V抑制剂滴度为13贝塞斯达单位,证实了AFVD的诊断。由于抗生素未被认定为病因,再次使用抗生素后凝血异常恶化。随后,通过输注血小板和给予氨甲环酸,黑便情况有所改善,而对泼尼松龙耐药的凝血异常通过环孢素A(CsA)治疗得到改善。该病例显示了避免使用可疑药物的重要性以及CsA作为AFVD二线治疗药物的有效性。